Yoo DC, Noto RB, Mazzaglia PJ. Controversy over radioiodine ablation in thyroid cancer: who benefits? Surgical Clinics of North America. S2014 Jun;94(3):573-586
Yoo DC, Dupuy DE, Hillman SL, Fernando HC, Rilling WS, Shepard JA, Siegel BA. Radiofrequency ablation of medically inoperable stage IA non-small cell lung cancer: are early posttreatment PET findings predictive of treatment outcome? American Journal of Roentgenology 2011 Aug;197(2):334-40.
Consultant and author of the Nuclear Medicine Section. Reference Levels and Achievable Doses in Medical and Dental Imaging: Recommendation for the United States. National Council on Radiation Protection & Measurements. NCRP Report No. 172. Bethesda MD Sept. 30, 2012